Login | Sign up
lavondaden

How To Win Clients And Influence Markets with Xarelto Lawsuit

Oct 28th 2017, 5:48 am
Posted by lavondaden
117 Views
Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical companies, which includes the makers of Xarelto, possess a duty to make sure that their drugs are reasonably secure for use - and failure to do so may be grounds for compensation. Our lawyers are operating tough to acquire these hurt by the drug the compensation they are entitled to.

While bleeding is a typical complication related with anticoagulants, it has been alleged that Xarelto is more unsafe than classic blood thinners simply because no antidote exists to reverse its blood-thinning effects. This indicates that, inside the occasion of an emergency, patients may be at risk for irreversible bleeding issues, like life-threatening internal and gastrointestinal hemorrhaging.

If you or perhaps a loved one suffered a severe bleeding event after taking Xarelto, you might have legal recourse. For far more details, speak to us these days to possess your case reviewed, totally free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future healthcare bills, lost wages, pain and suffering and, in situations of death, funeral expenditures. Furthermore, they are in search of punitive damages, which are typically awarded to punish the defendant and deter other businesses from acting similarly.
Why Are Lawsuits Getting Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs inside the lawsuits allege critical and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.

Visit this see page for far more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.

Tags:
xarelto patient information(1), side effects to xarelto(1), manufacturer of xarelto(1)

Bookmark & Share: